首页> 外文期刊>Pathology >Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia.
【24h】

Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia.

机译:作为甲磺酸伊马替尼治疗的慢性粒细胞白血病的晚期形态学改变,骨髓的明胶转化。

获取原文
获取原文并翻译 | 示例
           

摘要

Gelatinous transformation of the bone marrow is a well recognised pathological manifestation in people with cachex-ia consequent to malignancy, chronic infections or anorexia nervosa.1 However, with the advent of imatinib for the treatment of chronic myeloid leukaemia, there appears to be an emerging new cause for this manifestation.A 44-year-old male nurse was referred to the Haematology Department with characteristic peripheral blood, bone marrow and cytogenetic features of chronic myeloid leukaemia (CML) in chronic phase. He was completely asymptomatic at diagnosis.
机译:骨髓的胶质转化是恶性肿瘤,慢性感染或神经性厌食症所致恶病质患者的一种公认的病理学表现。1然而,随着伊马替尼的出现,用于治疗慢性粒细胞白血病,似乎正在出现这种表现的新原因。一名44岁的男护士被转诊至血液学部门,该患者具有慢性阶段性慢性粒细胞白血病(CML)的特征性外周血,骨髓和细胞遗传学特征。他在诊断时完全没有症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号